The 52-Week Low Club
As the market moves higher almost everyday, the membership in the Club becomes more exclusive. NeuroChem (NMRX) Negative news about phase 3 clinical trial data for its Alzheimer’s drug candidate, Alzhemed, followed by an $80 million in convertible notes. Brutal…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
As the market moves higher almost everyday, the membership in the Club becomes more exclusive.
NeuroChem (NMRX) Negative news about phase 3 clinical trial data for its Alzheimer’s drug candidate, Alzhemed, followed by an $80 million in convertible notes. Brutal day for the shareholder. Down 22% to $9.06, and moving further off the 52-week high of $26.91.
Harris Stratex Networks (HSTX) Wireless transmissions systems supplier is another 20% decliner today on poor earnings outlook. Falls to $14.85 down from 52-week high of $21.25.
AudioCodecs (AUDC) Joins the club again. Downgrade from Piper Jaffray after Q1 loss. Drops to $5.86 from 52-week high of $14.00.
Power-One (PWER) Wall Street Journal said management sold shares before bad news. Big loss from operations in last quarter from designer and manufacturer of power conversion products. Drops to $4.02 from 52-week high of $8.15.
Douglas A. McIntyre
Contact [email protected] for any questions or corrections.
